The answer to my Viagra question comes (indirectly) from WO9716181, a Univ
Kentucky case first highlighted in a press release dated Jan 14th (1999)
from Reuters, entitled "Scientists champion fast-acting Viagra nasal spray".
These scientists have been investigating intranasal drug administration
(including aspirin, WO9001322) for many years - and maybe it was predicatble
that they should now turn their attention to sildenafil. Many thanks for
this clarification (and to A Belinsky). I wonder if this prior art will be
cited against (all three of) the pending applications.
Thanks, Serge, wherever you are. This intelligence may qualify you for a
sample of the CPG issue in question....
Regards
Peter Steele
Managing Director, Current Patents Ltd
Middlesex House, 34-42 Cleveland Street
London W1P 6LB, UK
Tel: +44 (0)171 323 0323
Fax: +44 (0)171 580 5646
E-mail: peter.steele@cursci.co.uk
-----Original Message-----
From: Dorofeev Serge [mailto:dor@mail.stirol.donetsk.ua]
Sent: 10 January 2000 11:17
To: ABelinskiy@aol.com
Cc: Peter.Steele@cursci.co.uk
Subject: Re: Inquiry about nasal administration of Viagra from 1998
Digest ofnews
Importance: High
Dear Mr. Belinsky,
Please find attached the January 14 1999 Reuters news release concerning
nasal administration of Viagra.
Yours sincerely,
Serge Dorofeev
This archive was generated by hypermail 2b29 : Fri Aug 10 2001 - 15:58:02 EDT